Gut bacterial and fungal dysbiosis in tuberculosis patients

Background Recent studies have more focused on gut microbial alteration in tuberculosis (TB) patients.

However, no detailed study on gut fungi modification has been reported till now.

So, current research explores the characteristics of gut microbiota (bacteria)- and mycobiota (fungi)-dysbiosis in TB patients and also assesses the correlation between the gut microbiome and serum cytokines.

It may help to screen the potential diagnostic biomarker for TB.

Results The results show that the alpha diversity of the gut microbiome (including bacteria and fungi) decreased and altered the gut microbiome composition of TB patients.

The bacterial genera Bacteroides and Prevotella were significantly increased, and Blautia and Bifidobacterium decreased in the TB patients group.

The fungi genus Saccharomyces was increased while decreased levels of Aspergillus in TB patients.

It indicates that gut microbial equilibrium between bacteria and fungi has been altered in TB patients.

The fungal-to-bacterial species ratio was significantly decreased, and the bacterial-fungal trans-kingdom interactions have been reduced in TB patients.

A set model including Bacteroides, Blautia, Eubacterium_hallii_group, Apiotrichum, Penicillium , and Saccharomyces may provide a better TB diagnostics option than using single bacterial or fungi sets.

Also, gut microbial dysbiosis has a strong correlation with the alteration of IL-17 and IFN-γ.

Conclusions Our results demonstrate that TB patients exhibit the gut bacterial and fungal dysbiosis.

In the clinics, some gut microbes may be considered as potential biomarkers for auxiliary TB diagnosis.